Changing stroke rehab and research worldwide now.Time is Brain! trillions and trillions of neurons that DIE each day because there are NO effective hyperacute therapies besides tPA(only 12% effective). I have 523 posts on hyperacute therapy, enough for researchers to spend decades proving them out. These are my personal ideas and blog on stroke rehabilitation and stroke research. Do not attempt any of these without checking with your medical provider. Unless you join me in agitating, when you need these therapies they won't be there.

What this blog is for:

My blog is not to help survivors recover, it is to have the 10 million yearly stroke survivors light fires underneath their doctors, stroke hospitals and stroke researchers to get stroke solved. 100% recovery. The stroke medical world is completely failing at that goal, they don't even have it as a goal. Shortly after getting out of the hospital and getting NO information on the process or protocols of stroke rehabilitation and recovery I started searching on the internet and found that no other survivor received useful information. This is an attempt to cover all stroke rehabilitation information that should be readily available to survivors so they can talk with informed knowledge to their medical staff. It lays out what needs to be done to get stroke survivors closer to 100% recovery. It's quite disgusting that this information is not available from every stroke association and doctors group.

Tuesday, September 25, 2012

Myelin associated inhibitors; molecular mechanisms and therapeutic potential

A great thesis, why can't regular stroke researchers come up with novel ideas to research like this? Only 59 pages for your doctor to read and explain to you.
http://igitur-archive.library.uu.nl/student-theses/2012-0919-200507/Myelin%20inhibitors.pdf
Summary
Whereas the peripheral nervous system can readily regenerate after injury, regeneration is very limited in the central nervous system of adult vertebrates. Over the past three decades, it has become clear that this lack of regeneration has a molecular basis. The myelin that provides electrical insulation of neuronal fibers has a different composition in the central nervous system, as compared to peripheral nervous system myelin. Several proteins expressed on myelin have been found to have inhibitory effects for neuronal regeneration and were dubbed myelin-associated inhibitors. The three classical myelin-associated inhibitors (Nogo, MAG and OMgp) were found to signal all three through two distinct receptor complexes, providing a puzzling redundancy for these interactions. This signaling is speculated to be important for stabilizing neuronal circuitry in healthy adult organisms. Other proteins known to be involved in axonal guidance, such as semaphorins, ephrins, netrins and Wnts, as well as extracellular matrix components such as the chondroitin sulfate proteoglycans, have also been shown to have regeneration inhibitory effects. Downstream signaling by neuronal effector proteins culminates in modulation of the cytoskeleton and transcription, explaining the morphological changes of the neurons that are observed upon signaling. The fact that the lack of regeneration has a molecular basis provides prospects for therapeutic intervention to stimulate regeneration for injuries of the central nervous system, like spinal cord injury or stroke. Indeed, a substantial body of different proteins, peptides and small molecules that intervene with the different steps involved in the inhibition of regeneration shows promising effects, both in vitro and in vivo.
This review will discuss the advances made on understanding the lack of regeneration in the central nervous system. After an introduction on the nervous system, injury and regeneration, the molecular mechanisms of inhibition will be discussed. A special focus will be on the three classical myelin associated inhibitors and their receptor complexes, but other molecules that are inhibitory for regeneration will be discussed as well. The current understanding of the downstream signaling cascades of the myelin associated inhibitors will be reviewed and finally, different strategies that demonstrate the therapeutic potential of interfering with these mechanisms will be discussed.

Table of content
Summary ................................................................................................... 2
Table of content .......................................................................................... 3
Introduction ............................................................................................... 4
Molecular Mechanisms ................................................................................. 9
Downstream Events ................................................................................... 32
Therapeutic Potential ................................................................................. 39
Conclusion and Perspectives ....................................................................... 46
List of Abbreviations .................................................................................. 47

No comments:

Post a Comment